Source - LSE Regulatory
RNS Number : 7366C
Renalytix AI PLC
22 June 2021
 

The following amendment(s) has been made to the ' Director/PDMR Dealing' announcement released on 22 June 2021 at 10:57 under RNS No 7062C.

 

The price of 113.5 pence per share was incorrect and has been amended to 1135 pence per share.

The Company was also informed of the sale 'yesterday'.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Renalytix AI plc 

 

("Renalytix" or the "Company")

 

Director/PDMR Dealing

 

The Company was informed that yesterday, Christopher Mills, a non-executive director and interim Chairman, completed the sale of 17,000 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 1135 pence per share.

 

Following completion of the sale, Christopher Mills is interested in 9,180,501 Ordinary Shares representing 12.74% of the current issued share capital of the Company.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

Harwood Capital LLP and Harwood Capital Management (Gibraltar) Limited as investment manager to North Atlantic Smaller Companies Investment Trust plc and Oryx

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Christopher Mills, non-exec director and Interim Chair of the issuer and director of NASCIT and Oryx International Growth Fund Ltd

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Renalytix AI plc

b)

 

LEI

 

 

213800NTOH3FK3WER551

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of  £0.0025 each



Identification code

GB00BYWL4Y04

 

 


b)

 

Nature of the transaction

 

 

Sale of shares

c)

Currency

GBP

d)

 

Price(s) and volume(s)

 

 

 

 


 

Price(s)

Volume(s)

 


 

£11.352941

17,000

 


 

 

 

 

e)

 

Aggregated information




- Aggregated volume

17,000



- Price

£192,999.99



f)

 

Date of the transaction

 

 

18 June 2021

g)

 

Place of the transaction

 

 

London Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZZGZVZZFGMZM
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJBell logo

Related Charts

Renalytix PLC (RENX)

-1.50p (-4.29%)
delayed 16:57PM